Skip to main content
Log in

Reply: Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tahara K, Mimori K, Iinuma H, et al. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal Cancer. Ann Surg Oncol. 2010.

  2. Jung K, Lein M, Laube C, Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta. 2001;314(1–2):241–4.

    Article  PubMed  CAS  Google Scholar 

  3. Green MJ, Gough AK, Devlin J, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxf). 2003;42(1):83–8.

    Article  CAS  Google Scholar 

  4. Myers A, Lakey R, Cawston TE, et al. Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings. Rheumatology (Oxf). 2004;43(3):272–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaaki Iwatsuki MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwatsuki, M., Mimori, K., Tahara, K. et al. Reply: Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer. Ann Surg Oncol 18 (Suppl 3), 233–234 (2011). https://doi.org/10.1245/s10434-010-1498-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1498-x

Keywords

Navigation